@FierceMedDev: DNA in Play as Life Technologies Joins Illumina in Race for Deal: Real M&A via @BloombergNews. Item | Follow @FierceMedDev
> Stryker ($SYK) isn't the only organization that will be missing the presence of Stephen MacMillan, its erstwhile CEO. MacMillan has also resigned from Texas Instruments' board of directors. "It was a personal decision on his part," TI spokeswoman Whitney Jodry said in email to the The Dallas Morning News. "There was no issue between him and the board or TI. Steve was an excellent board member during his tenure." Item
> A new app could help stroke victims get the care they need faster, according to researchers at the University of Edinburgh. The app, which is known as Fast, identifies key symptoms of a stroke, and the researchers hope it will help diagnosis, treatment and prevention in the future. News
> Acquisition-hungry Thermo Fisher Scientific ($TMO) is taking it down a notch in 2012. CEO Marc Casper tells Bloomberg that after making 5 acquisitions last year, it will use its cash to pay down its $7 billion in debt. Story
> BSD Medical ($BSDM) has started a randomized, multicenter, Phase III clinical study using the BSD-2000 hyperthermia system to deliver hyperthermia in combination with chemotherapy for the treatment of pancreatic cancer patients. BSD release
> Roche Holding is hoping to extend the acceptance period on its $5.7 billion cash offer for U.S.-based Illumina ($ILMN). News
> Scientists at the University of Auckland have developed a motor made from artificial muscles, an accomplishment that the researchers believe could lead to better technology in prosthetics, among other indications. Release
And Finally... Ada Poon has demonstrated that a tiny, wirelessly powered, self-propelled medical device capable of controlled motion through blood could usher in the era of swallow-the-surgeon medical care. Item